Results 281 to 290 of about 8,029,668 (390)
Adapting genetic algorithms for artificial evolution of visual patterns under selection from wild predators. [PDF]
Briolat ES, Hancock GRA, Troscianko J.
europepmc +1 more source
Correspondence of MRI and nTMS With EDSS in Multiple Sclerosis: Longitudinal Follow‐Up Study
ABSTRACT Objectives Considering the characteristics of multiple sclerosis (MS) disease and its impact on motor disability, this study aims to assess the functional integrity of the corticospinal tract by examining motor evoked potentials (MEPs), Expanded Disability Status Scale (EDSS) scores, magnetic resonance imaging (MRI) lesion counts, and ...
Antonia Bralić+13 more
wiley +1 more source
Deciphering Double-Walled Corrugated Board Geometry Using Image Analysis and Genetic Algorithms. [PDF]
Rogalka M, Grabski JK, Garbowski T.
europepmc +1 more source
A hybrid genetic algorithm for a type of nonlinear programming problem
Jiafu Tang+3 more
openalex +1 more source
ABSTRACT Background and Objectives Ofatumumab, a fully human anti‐CD20 monoclonal antibody, is effective in reducing relapses and disability progression in patients with multiple sclerosis. This study aimed to examine immune profile changes associated with ofatumumab in a prospective cohort of Chinese patients with relapsing–remitting multiple ...
Shu Yang+9 more
wiley +1 more source
ABSTRACT Objective Quantitative markers of cortical excitability may help identify responders to anti‐seizure medications (ASMs). We studied the relationship between ASM load and two electroencephalography (EEG) markers of cortical excitability in people with refractory epilepsy. Methods We included individuals with refractory focal epilepsy undergoing
Silvano R. Gefferie+7 more
wiley +1 more source
Hyperparameter Optimization with Genetic Algorithms and XGBoost: A Step Forward in Smart Grid Fraud Detection. [PDF]
Mehdary A+3 more
europepmc +1 more source
ABSTRACT This study assessed whether continued treatment with anti‐CGRP monoclonal antibodies (mAbs) is driven more by reductions in monthly migraine days (MMDs) or patients' global impression of change (PGIC), a patient‐reported outcome. Among 169 patients treated with anti‐CGRP mAbs, 21.3% discontinued due to ineffectiveness. PGIC responders (≥ 5) at
Marina Romozzi+4 more
wiley +1 more source
Optimizing PCF-SPR sensor design through Taguchi approach, machine learning, and genetic algorithms. [PDF]
Kaziz S, Echouchene F, Gazzah MH.
europepmc +1 more source